In the healthcare sector a key challenge for business and practitioners alike is the development and adoption of high quality rapid diagnostic devices for infectious diseases, in line with the priorities identified by the Department of Health and the Department for Environment, Food and Rural Affairs. This is the focus of the Technology Strategy Board’s Innovation Platform on the Detection & Identification of Infectious Agents (DIIA).

 

Clinically useful diagnostics should be decision making tools that provide solutions to unmet needs and play a critical role in disease/ health management. Introducing clinically useful diagnostic devices at the point of care is especially challenging, as a change in the way patients are managed may be needed; with implications for staff responsibilities, training needs and hospital management. To be commercially viable and sustainable, these innovative devices will need to be sufficiently rapid, sensitive, specific to individual diseases and effective for both positive and negative results.

 

This seminar is aimed at diagnostic developers and businesses as well as healthcare providers interested in the adoption of point-of-care diagnostics into the NHS.

 

Join the Technology Strategy Board’s DIIA Innovation Platform leaders, Dr Meredith Bradbury and Dr Penny Wilson, to look at this topic from both a clinical and a business perspective.